Interaction between pharmaceutical companies and physicians who prescribe antiretroviral drugs for treating AIDS
Keywords:
Drug industry, Drug prescriptions, Ethics, medical, Anti-retroviral agents, Acquired immunodeficiency syndromeAbstract
CONTEXT AND OBJECTIVE: Given that Brazil has a universal public policy for supplying medications to treat HIV and AIDS, the aim here was to describe the forms of relationship between physicians and the pharmaceutical companies that produce antiretrovirals (ARVs). DESIGN AND SETTING: Cross-sectional epidemiological study conducted in the state of São Paulo. METHODS: Secondary database linkage was used, with structured interviews conducted by telephone among a sample group of 300 physicians representing 2,361 professionals who care for patients with HIV and AIDS. RESULTS: Around two thirds (64%) of the physicians prescribing ARVs for HIV and AIDS treatment in the state of São Paulo who were interviewed declared that they had some form of relationship with pharmaceutical companies, of which the most frequent were receipt of publications (54%), visits by sales promoters (51%) and receipt of small-value objects (47%). CONCLUSIONS: Two forms of relationship between the pharmaceutical industry and physicians who deal with HIV and AIDS can be highlighted: facilitation of professionals’ access to continuing education; and antiretroviral drug brand name promotion.
Downloads
References
Dalgalarrando S. Sida: la course aux molécules. Paris: Éditions de l’École des Hautes Études en Sciences Sociales; 2004.
Fauci AS. Twenty-five years of HIV/AIDS. Science. 2006;313(5786):409.
Dodier N. Leçons politiques de l’épidémie de sida. Paris: Éditions de l’École des Hautes Études en Sciences Sociales; 2003.
Capanema LXL, Palmeira Filho PL. A cadeia farmacêutica e a política industrial: uma proposta de inserção do BNDES. BNDES Setorial 2004;19:23-48. Available from: http://www.bndes.gov.br/SiteBNDES/export/sites/default/bndes_pt/Galerias/Arquivos/conhecimento/bnset/set1902.pdf. Accessed in 2013 (Jun 25).
Hallal R, Ravasi G, Kuchenbecker R, Greco D, Simão M. O acesso universal ao tratamento antirretroviral no Brasil [Access to antiretroviral treatment in Brazil]. Revista Tempus Actas em Saúde Coletiva. 2010;4(2):53-65.
Scheffer MC, Escuder MM, Grangeiro A, Castilho EA. Formação e experiência profissional dos médicos prescritores de antirretrovirais no Estado de São Paulo [Professional background and experience of antiretroviral prescribing physicians in the State of São Paulo]. Rev Assoc Med Bras (1992). 2010;56(6):691-6.
Brasil. Ministério da Saúde. Boletim Epidemiológico – AIDS e DST 2012. Available from: http://www.aids.gov.br/sites/default/files/anexos/publicacao/2011/50652/boletim_aids_2011_final_m_pdf_26659.pdf. Accessed in 2013 (Jun 25).
Rosner B. Fundamentals of bioesatistics. Boston: Duxbury Press; 1986.
Conselho Regional de Medicina do Estado de São Paulo (Cremesp). Pesquisa Inédita do Cremesp. Available from: http://www.cremesp.org.br/pdfs/pesquisa.pdf. Accessed in 2013 (Jun 25).
Grande D. A national survey of physician-industry relationships. N Engl J Med. 2007;357(5):507-8, author reply 508.
Pepe VLE, Veras CMT. A prescrição médica. Rio de Janeiro: Instituto de Medicina Social/Universidade Estadual do Rio de Janeiro; 1995.
Carré-Auger E, Charpiat B. Les prescriptions hors AMM: revue de la littérature. Journal de Pharmacie Clinique. 1998;17(4):187-94. Available from: http://www.jle.com/e-docs/00/02/71/DC/article.phtml. Accessed in 2013 (Jun 25).
Massud M. Conflito de interesses entre os médicos e a indústria farmacêutica. Revista Bioética. 2010;18(1):75-91. Available from: http://revistabioetica.cfm.org.br/index.php/revista_bioetica/article/viewFile/537/523. Accessed in 2013 (Jun 25).
Stamatakis E, Weiler R, Ioannidis JP. Undue industry influences that distort healthcare research, strategy, expenditure and practice: a review. Eur J Clin Invest. 2013;43(5):469-75.
